Clinical Trials
All Clinical Trials - Page 8 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07135141N/ANot Yet Recruiting
Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
Mazdutide
- NCT07202884Phase 3Recruiting
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
Orforglipron
- NCT07083154Phase 3Recruiting
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Mazdutide
- NCT07184086Phase 1Recruiting
A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet
Semaglutide
- NCT06441331Phase 1Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Octreotide
- NCT07150975Phase 3Recruiting
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Semaglutide
- NCT07216651N/ACompleted
WeDosify Real World Evidence (RWE) Study: Personalized Semaglutide Dosing in U.S. Adults
Semaglutide
- NCT06760546Phase 3Recruiting
A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)
Setmelanotide
- NCT07203677N/ACompleted
Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
Tirzepatide
- NCT06847399Phase 2Recruiting
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
Tirzepatide
- NCT06727331Phase 2Recruiting
Study of Tirzepatide for Recovery and Alcohol Use Management
Tirzepatide
- NCT07188545N/AActive Not Recruiting
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)
Tirzepatide
- NCT07152756N/ANot Yet Recruiting
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
Semaglutide
- NCT07165158Phase 4Not Yet Recruiting
The Effect of Semaglutide on Bone Health
Semaglutide
- NCT07156591N/ANot Yet Recruiting
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Semaglutide
- NCT07035704N/ANot Yet Recruiting
Prevent and Reverse Obesity in Children, Adolescents and Young Adults
Semaglutide
- NCT07153471Phase 3Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Orforglipron
- NCT07152730Phase 1Withdrawn
A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod Pump
Gonadorelin
- NCT07169136N/ARecruiting
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
Semaglutide
- NCT07091734Phase 2Recruiting
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Tirzepatide
- NCT07314684Phase 4Recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM
Semaglutide
- NCT07752381N/ACompleted
A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
BPC-157
- NCT07171723Phase 1/Phase 2Recruiting
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Semaglutide
- NCT07262957Phase 4Recruiting
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Octreotide
- NCT07099742N/ANot Yet Recruiting
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
Tirzepatide
- NCT07139548Phase 3Not Yet Recruiting
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
Semaglutide
- NCT07616401N/ARecruiting
MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis
Abaloparatide
- NCT07141914N/ACompleted
A Master Protocol for Semaglutide Effects on Cardiovascular and Obesity-related Outcomes in People With Overweight or Obesity in the Real World
Semaglutide
- NCT07165886Phase 2/Phase 3Recruiting
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Octreotide
- NCT07112872Phase 2Active Not Recruiting
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
Semaglutide
- NCT07121153Phase 1Completed
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.
Amycretin
- NCT07115069N/AActive Not Recruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Tirzepatide
- NCT06885736N/ARecruiting
LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
Tirzepatide
- NCT06691243Phase 2Recruiting
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
Semaglutide
- NCT07160257Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT07621419N/ARecruiting
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Semaglutide
- NCT07319286Phase 1/Phase 2Enrolling By Invitation
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
Dulaglutide
- NCT07065383N/ARecruiting
Rebalancing the Fat Content of the Heart and Muscles
Semaglutide
- NCT07046273Phase 3Not Yet Recruiting
Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes
Semaglutide
- NCT07513168Phase 4Recruiting
Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults
Semaglutide
- NCT06832774Phase 2Recruiting
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
Gonadorelin
- NCT06073184Phase 2Not Yet Recruiting
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
Tirzepatide
- NCT07096908Phase 4Recruiting
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Tirzepatide
- NCT06903923Phase 2Recruiting
Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Semaglutide
- NCT07073417Phase 2Active Not Recruiting
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Semaglutide
- NCT07071974Phase 1Completed
A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT07037433Phase 3Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Maridebart-Cafraglutide
- NCT07065539N/ANot Yet Recruiting
GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients
Gonadorelin
- NCT06867835Phase 4Completed
Single Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk
PT-141
- NCT07254572Phase 4Recruiting
Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
Semaglutide